Evaxion A (EVAX) Tax Provisions (2020 - 2026)
Evaxion A posted quarterly Tax Provisions of $216000.0 for Q1 2026, up 12.5% year-on-year from $192000.0 in Q1 2025, and down 15.29% on a QoQ basis from $255000.0 in Q4 2025.
Evaxion A (EVAX) has 7 years of Tax Provisions data on file, last reported at $216000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions rose 12.5% year-over-year to $216000.0; the trailing twelve-month figure through Mar 2026 stood at $931000.0 (up 22.18% YoY), and the FY2025 full-year result was $908000.0, up 15.23% from the prior year.
- Tax Provisions for Q1 2026 stood at $216000.0, down from $255000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $275000.0 in Q4 2024 and bottomed at $96000.0 in Q3 2024.
- The 5-year median for Tax Provisions is $195000.0 (2025), against an average of $204294.1.
- The widest annual swing landed in 2022, when Tax Provisions slumped 73.54%; it then jumped 176.04% in 2025.
- A 5-year view of Tax Provisions shows it stood at $173000.0 in 2022, then gained by 2.31% to $177000.0 in 2023, then jumped by 55.37% to $275000.0 in 2024, then fell by 7.27% to $255000.0 in 2025, then decreased by 15.29% to $216000.0 in 2026.
- The last three Tax Provisions figures came in at $216000.0 (Q1 2026), $255000.0 (Q4 2025), and $265000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 216,000.00 |
| Dec 31, 2025 | 255,000.00 |
| Sep 30, 2025 | 265,000.00 |
| Jun 30, 2025 | 195,000.00 |
| Mar 31, 2025 | 192,000.00 |
| Dec 31, 2024 | 275,000.00 |
| Sep 30, 2024 | 96,000.00 |
| Jun 30, 2024 | 199,000.00 |
| Mar 31, 2024 | 218,000.00 |
| Dec 31, 2023 | 177,000.00 |
| Sep 30, 2023 | 194,000.00 |
| Jun 30, 2023 | 225,000.00 |
| Mar 31, 2023 | 194,000.00 |
| Dec 31, 2022 | 173,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 177,000.00 |
| Mar 31, 2022 | 247,000.00 |
| Dec 31, 2021 | -1.32 Mn |
| Sep 30, 2021 | 425,000.00 |
| Jun 30, 2021 | 669,000.00 |
| Mar 31, 2021 | 407,000.00 |
| Dec 31, 2020 | 503,000.00 |
| Sep 30, 2020 | 578,000.00 |
| Jun 30, 2020 | 296,000.00 |
| Mar 31, 2020 | 180,000.00 |